IRONWOOD PHARMACEUTICALS INC·4

Aug 17, 4:05 PM ET

Rickard Jason 4

4 · IRONWOOD PHARMACEUTICALS INC · Filed Aug 17, 2022

Insider Transaction Report

Form 4
Period: 2022-08-15
Rickard Jason
SVP, Chief Operating Officer
Transactions
  • Sale

    Class A Common Stock

    2022-08-15$11.77/sh994$11,699375,736 total
Footnotes (1)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on September 4, 2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION